Tradeoffs

When Picking an ACA Plan Becomes An Olympic Event

When Picking an ACA Plan Becomes An Olympic Event By Stacie Dusetzina, PhD July 23, 2021 Stacie Dusetzina is an associate professor of health policy at Vanderbilt University School of Medicine and a member of the 2021 Tradeoffs Research Council. Her research focuses on measuring and evaluating the costs of prescription drugs. The long-delayed and still…

Read More

Sacrifices and Small Wins: The Fight Against Rising Gun Violence

As gun violence continues to soar in U.S. cities, one violence prevention specialist tries to stem the tide of homicides in his hometown.

Read More

How Medicaid Helps The Next Generation

Atheendar Venkataramani writes about new research showing how Medicaid coverage can help someone who hasn’t even been born yet.

Read More

One Woman’s Year Surviving the Pandemic with a Disability

A young woman living with cerebral palsy shares the struggles, fears and silver linings she’s experienced during the pandemic.

Read More

The Role of Hospitals in COVID-19 Disparities

Adam Gaffney looks at new research linking hospitals to racial disparities in COVID-19 mortality.

Read More

Why Millions Could Lose Medicaid Next Year

A congressional ban on removing anyone from Medicaid is likely to expire early next year.

Read More

‘Why Millions Could Lose Medicaid Next Year’ Transcript

‘Why Millions Could Lose Medicaid Next Year’ Transcript July 8, 2021 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in Apple Podcasts…

Read More

How Do You Create a ‘Zero-Burnout’ Primary Care Practice?

Bianca Frogner on a new study highlighting common characteristics of primary care practices that avoid staff burnout.

Read More

One County’s 20-Year Effort to Decriminalize Mental Illness

Miami-Dade County has spent the last two decades trying to connect people in mental distress with services instead of jail cells. What have they learned?

Read More

The Aducanumab Aftermath: The Industry

How is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug?

Read More